Analyst firms · H.C. Wainwright · SMTI
H.C. Wainwright SMTI price target and rating history
Sanara MedTech Inc. (SMTI) · Health Care
H.C. Wainwright rates Sanara MedTech Inc. (SMTI) Neutral with a $35 price target, as of its latest action on Jul 30, 2026. It has published 3 rating actions on SMTI since December 2024, including 0 upgrades and 1 downgrade.
- Current rating
- Neutral
- Price target
- $35
- Median target, all firms
- Too few
- Actions on SMTI
- 3
H.C. Wainwright price target on SMTI
Every H.C. Wainwright rating on SMTI
- Jul 30, 2026
- Mar 26, 2025
- Dec 23, 2024
How other firms rate SMTI
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| H.C. Wainwright | Neutral | $35 | Jul 30, 2026 |
| Lake Street | Buy | $32 | Apr 15, 2026 |
Questions about H.C. Wainwright and SMTI
- What is H.C. Wainwright's price target for SMTI?
- H.C. Wainwright's latest stated price target for Sanara MedTech Inc. (SMTI) is $35, from its action on Jul 30, 2026.
- What is H.C. Wainwright's rating on SMTI?
- H.C. Wainwright rates SMTI Neutral, a neutral rating, as of Jul 30, 2026.
- When did H.C. Wainwright last change its view on SMTI?
- On Jul 30, 2026, H.C. Wainwright downgrades to Neutral from Buy, price target $35.
All H.C. Wainwright ratingsSMTI news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.